A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407)
Year: 2001
Type: article
Study design: Clinical Trial
Source: The Prostate
Institutions: University of Michigan, Michigan Medicine, SWOG Cancer Research Network, Johns Hopkins University, Johns Hopkins Hospital, Louisiana State University, Louisiana State University in Shreveport, Texas Tech University, University of Colorado Denver, Wayne State University, The Barbara Ann Karmanos Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: Southwest Oncology Group, G117886320, G1279808231, UCLA/JCCC--SOUTHWEST ONCOLOGY GROUP, G1790576020, G1958973285, G20028727, G2064543036, G2160369479, G2562936776, G268786457, G2745671310, Southwest Oncology Group, Southwest Oncology Group U10 Member Site, Ozark Health Ventures, LLC dba Cancer Research for the Ozarks, GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM, G3041257426, SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER, G313314762, G3411601502, G3497039781, G413878341, Southwest Oncology Group, Dayton Clinical Oncology Program, SOUTHWEST ONCOLOGY GROUP--CLINICAL TRIALS, G425646771, Southwest Oncology Group, G4292856267, SOUTHWEST ONCOLOGY GROUP, G4527800867, G5125348268, G6109875642, Southwest Oncology Group Treatment Grant, SOUTHWEST ONCOLOGY GROUP, Southwest Oncology Group, Atlanta Regional Community Clinical Oncology Program (ARCCOP), SOUTHWEST ONCOLOGY GROUP, SOUTHWEST ONCOLOGY GROUP STUDIES, University of Colorado Southwest Oncology Group, LSUHSC Minority-Based Community Clinical Oncology Program, SOUTHWEST ONCOLOGY GROUP STUDY, Community Clinical Oncology Program, Development of a Registry for Familial Pancreatic Cancer, G763325562, G860872252, PARTICIPATE AS MEMBER OF SOUTHWEST ONCOLOGY GROUP, G960417071, G971274320
OpenAlex ID: W2058040589